Literature DB >> 19351150

Cytoplasmic proteome and secretome profiles of differently stimulated human dendritic cells.

Nina C Gundacker1, Verena J Haudek, Helge Wimmer, Astrid Slany, Johannes Griss, Valery Bochkov, Christoph Zielinski, Oswald Wagner, Johannes Stöckl, Christopher Gerner.   

Abstract

Dendritic cells (DCs), the most potent and specialized antigen-presenting cells, play a key role in the regulation of the adaptive immunity. Immature DCs were generated by in vitro culturing of peripheral blood monocytes and functionally activated with the classical pathogen-associated molecular pattern lipopolysaccharide (LPS). Alternative activation resulting in Th-2 polarization was induced with lipid oxidation products derived from 1-palmitoyl-2-arachidoyl-sn-glycerol-3-phosphorylcholin (OxPAPC). Tolerogenic cells were obtained by treating DCs with human rhinovirus (HRV). The aim of this study was the identification of proteome profiles related to the functionally different dendritic cell phenotypes. Cytoplasmic proteins were analyzed by shotgun proteomics resulting in the identification of 1690 proteins. While mature and alternatively activated DCs displayed highly distinct protein expression profiles, HRV-treated DCs showed minor proteome alterations. As DCs exert many specific functions via secretion, we investigated the secretomes by a combination of 2D-PAGE and shotgun proteomics. We successfully identified a broad variety of cytokines (e.g., GM-CSF, TNF-alpha, interleukin-1beta, 6, 12 beta, 28B and 29), chemokines (e.g., CCL3, 5, 8, 17, 18, 19, 24, CXCL1, 2, 9 and 10) and growth factors (growth/differentiation factor 8, C-type lectin domain family 11 member A). The relative composition of secretome profiles, although comprising much less proteins, was found to be much more affected by functional alteration of cells than the cytoplasmic protein composition. In conclusion, we demonstrate that functional distinct subsets of DCs display distinct proteome profiles which comprise biomarker candidates. These proteins may prove useful for the interpretation of complex clinical proteomics data.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19351150     DOI: 10.1021/pr8011039

Source DB:  PubMed          Journal:  J Proteome Res        ISSN: 1535-3893            Impact factor:   4.466


  21 in total

1.  Serum amyloid A in uremic HDL promotes inflammation.

Authors:  Thomas Weichhart; Chantal Kopecky; Markus Kubicek; Michael Haidinger; Dominik Döller; Karl Katholnig; Cacang Suarna; Philipp Eller; Markus Tölle; Christopher Gerner; Gerhard J Zlabinger; Markus van der Giet; Walter H Hörl; Roland Stocker; Marcus D Säemann
Journal:  J Am Soc Nephrol       Date:  2012-01-26       Impact factor: 10.121

2.  Phosphatidylinositol-3-kinase activity during in vitro dendritic cell generation determines suppressive or stimulatory capacity.

Authors:  Valentina Di Caro; Antonella D'Anneo; Brett Phillips; Carl Engman; Jo Harnaha; Massimo Trucco; Nick Giannoukakis
Journal:  Immunol Res       Date:  2011-08       Impact factor: 2.829

Review 3.  Systems biology unravels interferon responses to respiratory virus infections.

Authors:  Andrea L Kroeker; Kevin M Coombs
Journal:  World J Biol Chem       Date:  2014-02-26

4.  Host-pathogen dynamics through targeted secretome analysis of stimulated macrophages.

Authors:  Mohd M Khan; Marijke Koppenol-Raab; Minna Kuriakose; Nathan P Manes; David R Goodlett; Aleksandra Nita-Lazar
Journal:  J Proteomics       Date:  2018-03-20       Impact factor: 4.044

5.  Optimization of human dendritic cell sample preparation for mass spectrometry-based proteomic studies.

Authors:  Ying Zhang; Dario Bottinelli; Frédérique Lisacek; Jeremy Luban; Caterina Strambio-De-Castillia; Emmanuel Varesio; Gérard Hopfgartner
Journal:  Anal Biochem       Date:  2015-05-15       Impact factor: 3.365

6.  Quantitative proteomic changes in LPS-activated monocyte-derived dendritic cells: A SWATH-MS study.

Authors:  Swati Arya; Dagmara Wiatrek-Moumoulidis; Silvia A Synowsky; Sally L Shirran; Catherine H Botting; Simon J Powis; Alan J Stewart
Journal:  Sci Rep       Date:  2019-03-13       Impact factor: 4.379

7.  Proteome signatures of inflammatory activated primary human peripheral blood mononuclear cells.

Authors:  Verena J Haudek-Prinz; Philip Klepeisz; Astrid Slany; Johannes Griss; Anastasia Meshcheryakova; Verena Paulitschke; Goran Mitulovic; Johannes Stöckl; Christopher Gerner
Journal:  J Proteomics       Date:  2012-07-16       Impact factor: 4.044

8.  Plasma membrane proteomes of differentially matured dendritic cells identified by LC-MS/MS combined with iTRAQ labelling.

Authors:  Stéphanie Ferret-Bernard; William Castro-Borges; Adam A Dowle; David E Sanin; Peter C Cook; Joseph D Turner; Andrew S MacDonald; Jerry R Thomas; Adrian P Mountford
Journal:  J Proteomics       Date:  2011-10-25       Impact factor: 4.044

9.  Proteomic detection of a large amount of SCGFα in the stroma of GISTs after imatinib therapy.

Authors:  Luca Da Riva; Fabio Bozzi; Piera Mondellini; Francesca Miccichè; Elena Fumagalli; Elena Vaghi; Eva Tarantino; Veronica Huber; Alessandro Gronchi; Elena Tamborini; Marco A Pierotti; Silvana Pilotti; Italia Bongarzone
Journal:  J Transl Med       Date:  2011-09-23       Impact factor: 5.531

10.  Plasticity of fibroblasts demonstrated by tissue-specific and function-related proteome profiling.

Authors:  Astrid Slany; Anastasia Meshcheryakova; Agnes Beer; Hendrik Jan Ankersmit; Verena Paulitschke; Christopher Gerner
Journal:  Clin Proteomics       Date:  2014-11-21       Impact factor: 3.988

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.